Open Access

Erratum to: The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b+ Ly6Chi cells to tumor tissue reduces tumor growth

  • Adnan Deronic1,
  • Sahar Tahvili1,
  • Tomas Leanderson1 and
  • Fredrik Ivars1Email author
BMC Cancer201616:610

https://doi.org/10.1186/s12885-016-2649-7

Received: 28 July 2016

Accepted: 28 July 2016

Published: 8 August 2016

The original article was published in BMC Cancer 2016 16:440

Erratum

After publication of this work [1], it was noted that co-author Sahar Tahvili was inadvertently missed from the author list. This has been corrected here, and in the original article. The publisher would like to apologize for any inconvenience this oversight may have caused.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Immunology group, Section for Immunology, Department of Experimental Medical Science, Lund University

Reference

  1. Deronic A, Tahvili S, Leanderson T, Ivars F. The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b + Ly6Chi cells to tumor tissue reduces tumor growth. BMC Cancer. 2016;16:440. doi:https://doi.org/10.1186/s12885-016-2481-0.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement